Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

GRAINPAD Private

Explore full profile

AI-powered virtual physician and healthcare chatbot services

Noida, IndiaFounded 2017Health
Valuation $50–100M Last recorded · 2021
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for GRAINPAD Private and the history behind them.

About GRAINPAD Private

GRAINPAD Private Limited is a research and innovation company operating in the health-tech sector, leveraging artificial intelligence, machine learning, and robotics. Founded in 2017 by Dr. Rohit Sharma and Raj Kumar Sehgal, the Delhi-based startup aims to make quality medical advice accessible and affordable. Dr. Sharma, a qualified physician, was motivated to start the company after observing that many people in India lacked access to reliable medical information, often relying on unlicensed practitioners.

The company's flagship product is ZINI, an AI-driven, voice-based virtual physician. This medical chatbot can conduct a full diagnostic interview based on initial symptoms, ask relevant follow-up questions, and provide a preliminary diagnosis. ZINI also suggests the urgency of the situation, the type of specialist needed, and available treatment options. The technology is designed to be integrated into hospital and clinic apps and websites (B2B) or used directly by consumers (B2C). For B2B clients, it serves to automate patient history collection and organize information for doctors. The B2C model offers a certain number of free evaluations before moving to a subscription plan. The company's clients include hospitals and telehealth platforms in India, the UAE, and the United States.

Beyond ZINI, GRAINPAD offers B2B services including data analytics, automation solutions, and chatbot design and integration. The company is also developing other products, such as TOBI, an autonomous logistics robot for warehouses, and Project ROBODOC, which will use medical sensors and computer vision to perform basic physical examinations. The company raised an undisclosed seed funding amount in November 2021.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Noida, India
Employees
3
Open positions
None listed
Dealroom signal
25.7/100
Industry
Health
Sector
Health, DNA, Genetics and genomics, Health Diagnostics, Physician Support Tools, Hard Tech
Business model
Manufacturing
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Nov 2021 $14M $55M Undisclosed ↗
GRANT✓Other financing 2021 $400K — Undisclosed —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

GRAINPAD Private website traffic

Latest recorded traffic for GRAINPAD Private is 570 monthly website visits, up 185% over the last three months. GRAINPAD Private's team grew 0% over the past year.

Latest monthly visits570 3-month web change+185% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Nucleus GenomicsOffers an all-in-one DNA health test, combining whole-genome sequencing with lifestyle factors to deliver the comprehensive insights into health and well-being New York City, United States Operational 44 $32M $56M
ColoAlertDevelops in-vitro diagnostic and RUO tests for clinical diagnostics in the area of human genetics Mainz, Germany Operational
Indicate SolutionsDeveloping a cheap, reliable, rapid, and easy-to-use device to detect DNA mutations in the blood of cancer patients at POC, allowing patients tailored treatment decisions immediately San Sebastián, Spain Operational
Arquer DiagnosticsArquer Diagnostics is a diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test Sunderland, United Kingdom Closed
CNA DiagnosticsA molecular diagnostics company developing novel diagnostic tests for a spectrum of complex diseases Calgary, Canada Operational
Ares GeneticsWholly owned subsidiary of Curetis GmbH, a developer of next-generation molecular diagnostic solutions for infectious diseases Vienna, Austria Operational
Lucira HealthIVD, Consumer Health, Disposable Testing Emeryville, United States Acquired
Probably GeneticProbably Genetic helps rare genetic disease patients get diagnosed San Francisco, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇳 India100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about GRAINPAD Private on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GRAINPAD Private’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.